High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

High Sensitive C-reactive Protein to Albumin Ratio in Acute Coronary Syndrome — Stella

Home/Acute Coronary Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to Acute Coronary Syndrome trials

Trial locations(1 site)

Egypt

Sohag faculty of medicine, Sohag

Key details

Sponsor

Sohag University

Enrollment target

~240 participants

Started

November 2024

Primary completion

November 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.